Stocks To Buy Now

Blog


Giggles N’ Hugs, Inc. (GIGL) Considering a Variety of Growth Avenues for its Kid-Friendly (and Healthy) Restaurant Concept

GIGL

When Giggles N’ Hugs opened its first location over five years ago, it was steadfast in its desire to offer a truly unique family restaurant concept while giving mom and dad a breather while shopping at the same time. Promoting a healthy menu and surroundings aimed to captivate and meet the needs of children, the company is well on its way to cornering a very lucrative niche for its shareholders. As of today, GIGL owns and operates three locations in greater Los Angeles, and it’s currently engaged in talks with some of the largest mall owners to expand its presence going forward.

The franchise business model could also result in an additional boost to the company’s promising growth potential should company management decide to pursue the strategy. In a recent news release, Joey Parsi, Chief Executive Officer said the company has received substantial interest from both large multi-unit franchising operators and individual franchisees regarding both domestic and international opportunities.

The company’s healthy menu continues to be one its most sustaining characteristics. High-quality organic food within a kid-friendly, casual dining area for adults featuring a huge play area is the model Giggles N’ Hugs has been successfully executing on. Parents can relax while their children get the kind of food their growing bodies need while enjoying the themed play areas. Giggles N’ Hugs is getting great reviews from its customers and mall owners at all of its L.A. locations. And don’t be surprised to see a Hollywood celebrity with their children enjoying the organic cuisine and relaxing environment!

For more information, visit www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

February 2, 2026

Cutaneous T-cell lymphoma (“CTCL”) remains a cancer with limited treatment options, persistent symptoms and long-term quality-of-life challenges for patients, even decades after its classification as a distinct disease. Despite medical advances in oncology, many people living with CTCL continue to cycle through therapies that offer only partial relief or introduce new burdens. Soligenix (NASDAQ: SNGX) […]

Rotate your device 90° to view site.